Literature DB >> 26079607

The MSC curtain that stops the immune system.

Arnold I Caplan1, J Michael Sorrell2.   

Abstract

We have evolved cellular mechanisms for protecting us from disabling intruders or injuries. The Mesenchymal Stem Cell, MSC, is derived from perivascular cells, pericytes that are liberated from their basement membrane tethers surrounding blood vessels upon injury or inflammation. These site-activated MSCs produce a curtain of immuno-modulation behind which slow and specific tissue regeneration takes place. In addition, the MSC senses the tissue microenvironment and adjusts the curtain and regenerative activity accordingly. This includes the production of antibiotic proteins like LL37 that both kills intruding bacteria on contact, but calls forth macrophage and other members of the hematopoietic system to further medicate the injury site. Indeed, MSCs appear to be local managers of the tissues' innate regenerative potential. Thus, I propose that MSC should denote "Medicinal Signaling Cells" since these cells are "drug stores" for sites of injury or inflammation.
Copyright © 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell-based therapy; Immunomodulatory; Mesenchymal Stem Cells; Pericytes; Trophic

Mesh:

Year:  2015        PMID: 26079607     DOI: 10.1016/j.imlet.2015.06.005

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  39 in total

1.  Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.

Authors:  Giuliana Castello Coatti; Miriam Frangini; Marcos C Valadares; Juliana Plat Gomes; Natalia O Lima; Natale Cavaçana; Amanda F Assoni; Mayra V Pelatti; Alexander Birbrair; Antonio Carlos Pedroso de Lima; Julio M Singer; Francisco Marcelo M Rocha; Giovani Loiola Da Silva; Mario Sergio Mantovani; Lucia Inês Macedo-Souza; Merari F R Ferrari; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

Review 2.  Enhancing the Therapeutic Potential of Mesenchymal Stem Cells with the CRISPR-Cas System.

Authors:  Daniel Mendes Filho; Patrícia de Carvalho Ribeiro; Lucas Felipe Oliveira; Ana Luiza Romero Terra Dos Santos; Ricardo Cambraia Parreira; Mauro Cunha Xavier Pinto; Rodrigo Ribeiro Resende
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

Review 3.  Survival of encapsulated islets: More than a membrane story.

Authors:  Uriel Barkai; Avi Rotem; Paul de Vos
Journal:  World J Transplant       Date:  2016-03-24

4.  Investigating the route of administration and efficacy of adipose tissue-derived mesenchymal stem cells and conditioned medium in type 1 diabetic mice.

Authors:  Seyed Mahmoud Hashemi; Zuhair Mohammad Hassan; Nikoo Hossein-Khannazer; Ali Akbar Pourfathollah; Sara Soudi
Journal:  Inflammopharmacology       Date:  2019-11-18       Impact factor: 4.473

5.  Macrophage Subpopulation Dynamics Shift following Intravenous Infusion of Mesenchymal Stromal Cells.

Authors:  Nina Kosaric; Waracharee Srifa; Clark A Bonham; Harriet Kiwanuka; Kellen Chen; Britta A Kuehlmann; Zeshaan N Maan; Chikage Noishiki; Matthew H Porteus; Michael T Longaker; Geoffrey C Gurtner
Journal:  Mol Ther       Date:  2020-05-30       Impact factor: 11.454

6.  Chondroitin Sulfate Immobilized on a Biomimetic Scaffold Modulates Inflammation While Driving Chondrogenesis.

Authors:  Bruna Corradetti; Francesca Taraballi; Silvia Minardi; Jeffrey Van Eps; Fernando Cabrera; Lewis W Francis; Salvatore A Gazze; Mauro Ferrari; Bradley K Weiner; Ennio Tasciotti
Journal:  Stem Cells Transl Med       Date:  2016-03-24       Impact factor: 6.940

7.  Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?

Authors:  Timothy E Krueger; Daniel L J Thorek; Alan K Meeker; John T Isaacs; W Nathaniel Brennen
Journal:  Prostate       Date:  2018-11-28       Impact factor: 4.104

8.  Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure.

Authors:  M V Pelatti; J P A Gomes; N M S Vieira; E Cangussu; V Landini; T Andrade; M Sartori; L Petrus; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

9.  Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures.

Authors:  W Nathaniel Brennen; L Nelleke Kisteman; John T Isaacs
Journal:  Prostate       Date:  2016-01-06       Impact factor: 4.104

10.  Interaction of allogeneic adipose tissue-derived stromal cells and unstimulated immune cells in vitro: the impact of cell-to-cell contact and hypoxia in the local milieu.

Authors:  Aleksandra N Gornostaeva; Elena R Andreeva; Polina I Bobyleva; Ludmila B Buravkova
Journal:  Cytotechnology       Date:  2017-10-03       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.